A. Timpanaro

Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma

K. Mamchaoui, J. Rössler, M. Bernasconi, 2022, Cancers.

Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma

M. Heller, P. Bode, A. Uldry, 2023, International journal of molecular sciences.

Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer.

Abhishek Mitra, S. Rossi, M. Losa, 2019, Cell metabolism.

CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in an orthotopic mouse model

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023 .

CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023, bioRxiv.

The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics.

Marcel Garcia, F. Cunin, V. Sol, 2020, Biomaterials science.

CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023, Journal of Experimental & Clinical Cancer Research.

Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells.

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.